MARK J. AHN, PH.D. - Corporate Board Profile

ABEONA THERAPEUTICS INC.

Filing Date	Source Excerpt
2007-04-13	Dr. Mark J. Ahn became a director in September 2006. ... The Board has established an Executive Committee consisting of Mr. Davis, Mr. Seiler and Dr. Ahn. ... The table below represents the compensation paid to our directors during the year ended December 31, 2006: Mark J. Ahn, PhD: Fees earned or Paid in Cash ($) 4,000, Option Awards ($) 7,592, Total ($) 11,592.
2008-04-22	Dr. Mark J. Ahn became a director in September 2006 and is a member of the Executive Committee and the Nominating & Corporate Governance Committee. ... Director Compensation Table - 2007: Mark J. Ahn total compensation $18,000.
2009-04-22	Dr. Mark J. Ahn became a director in September 2006 and is a member of the Nominating & Corporate Governance Committee. ... Mark J. Ahn, PhD Fees earned or Paid in Cash ($) 16,000 Option Awards ($)(1) 16,000 Total ($) 32,000.
2010-04-16	Dr. Mark J. Ahn became a director in September 2006 and is chairman of the Compensation Committee. Dr. Ahn is also a member of the Audit and Finance Committee and the Nominating & Corporate Governance Committee. ... Dr. Ahn has options to purchase 66,000 shares of our Common Stock at December 31, 2009.
2011-04-14	Mark J. Ahn, Ph.D., a Director, received payments for consulting services and reimbursement of direct expenses for scientific consulting in 2010. Dr. Ahn’s payments for consulting services and expense reimbursements are as follows: $5,000 consulting fees, $4,000 expense reimbursement, $23,000 restricted stock; The Audit Committee is currently comprised of Mr. Mark J. Alvino (chairman) and Mr. Mark J. Ahn. The Compensation Committee is currently comprised of Mr. Mark J. Ahn (chairman) and Dr. Stephen B. Howell. The Nominating and Corporate Governance Committee is currently comprised of Mark Ahn, PhD and Mark J. Alvino.
2012-04-16	The Audit Committee is currently comprised of Mr. Mark J. Alvino (chairman) and Mr. Mark J. Ahn. The Compensation Committee is currently comprised of Mr. Mark J. Ahn (chairman) and Dr. Stephen B. Howell. The Nominating and Corporate Governance Committee is currently comprised of Mark Ahn, PhD and Mark J. Alvino. Dr. Ahn received options to purchase 35,000 shares of our common stock based on a grant date fair value of $67,000.
2013-04-02	Mark J. Ahn, Ph.D. became a director in September 2006 and is chairman of the Compensation Committee. Dr. Ahn is also a member of the Audit Committee and the Nominating & Corporate Governance Committee. Dr. Ahn currently serves as President and Chief Executive Officer since 2011 and as a director since 2007 of Galena Biopharma; and adjunct Professor, Biosciences at Creighton University. He brings more than 20 years of experience in the biopharmaceutical industry. Prior to joining Galena, Dr. Ahn was Principal at Pukana Partners, Ltd. which provides strategic consulting to life science companies; and Associate Professor, Global Management at Atkinson Graduate School of Management, Willamette University. He previously served as Professor and Chair, Science & Technology Management, Victoria University at Wellington, New Zealand. Dr. Ahn was also founder, President, and Chief Executive Officer of Hana Biosciences. Prior to joining Hana, he served as Vice President, Hematology and corporate officer at Genentech, Inc., and held positions of increasing responsibility at Amgen and Bristol-Myers Squibb. Dr. Ahn also serves on public and venture capital-backed board of directors for Galena, Mesynthes and ScribesSTAT. Dr. Ahn is the author of over 50 peer reviewed journal articles and books. Dr. Ahn received a B.A. and M.B.A. from Chaminade University; and M.A. from Victoria University. He was a graduate fellow in Economics at Essex University, and obtained a Ph.D. from the University of South Australia. Dr. Ahn is a Henry Crown Fellow at the Aspen Institute.
2014-04-15	Mark J. Ahn, Ph.D. became a director in September 2006 and is chairman of the Compensation Committee. Dr. Ahn is also a member of the Audit Committee and the Nominating & Corporate Governance Committee.
2015-04-07	Mark J. Ahn, Ph.D. 52 Director ... Dr. Ahn is chairman of the Compensation Committee of the Board and also a member of the Audit Committee and the Nominating & Corporate Governance Committee. ... The table below represents the compensation paid to our outside directors during the year ended December 31, 2014: Mark J. Ahn, Ph.D. 69,000 ... Dr. Ahn became a director in September 2006 and is Vice Chairman of the Board of Directors as of January 1, 2015.
2016-04-06	Dr. Ahn is chairman of the Compensation Committee of the Board and also a member of the Nominating & Corporate Governance Committee. ... During 2015, Dr. Ahn, as Vice Chairman, from May 1, 2015, received a monthly director fee of $23,750. ... Dr. Ahn received total compensation of $2,839,000 in 2015.